title: Clinical aspects of physical exercise for diabetes/metabolic syndrome.
abstract: Evidence-based medicine (EBM) has come to be regarded as essential in all fields of medical sciences and practical medicine. In the field of diabetes and exercise, among the epidemiological studies of physical exercise, recent mega-trials such as the Diabetes Prevention Program (DPP) in the U.S. have shown that lifestyle intervention programs involving diet and/or exercise reduce the progression of impaired glucose tolerance (IGT) to type 2 diabetes. In studies examining the endocrinological and metabolic effects of exercise, it has been demonstrated that physical exercise promotes the utilization of blood glucose and free fatty acids in muscles and lowers blood glucose levels in well-controlled diabetic patients. Long-term, mild, regular jogging increases the action of insulin in both carbohydrate and lipid metabolism without influencing body mass index or maximal oxygen uptake. A significant correlation has been observed between delta MCR (Deltainsulin sensitivity) and the average number of steps performed in a day. Our recent data suggested that the improved effectiveness of insulin that occurs as a result of physical exercise is attributable, at least in part, to increases in GLUT4 protein, IRS1 and PI3-kinase protein in skeletal muscle. As a prescription for exercise, aerobic exercise of mild to moderate intensity, including walking and jogging, 10-30 min a day, 3-5 days a week, is recommended. Resistance training of mild intensity with the use of light dumbbells and stretch cords should be combined in elderly individuals who have decreased muscle strength. An active lifestyle is essential in the management of diabetes, which is one of typical lifestyle-related diseases.
authors.affiliation: Department of Health Science, Faculty of Psychological and Physical Science, Aichi Gakuin University, Nisshin 470-0195, Japan. satoy@dpc.agu.ac.jp
authors.forename: Yuzo
authors.initials: Y
authors.lastname: Sato
authors.forename: Masaru
authors.initials: M
authors.lastname: Nagasaki
authors.forename: Masakazu
authors.initials: M
authors.lastname: Kubota
authors.forename: Tomoko
authors.initials: T
authors.lastname: Uno
authors.forename: Naoya
authors.initials: N
authors.lastname: Nakai
mesh_terms: D003920:Diabetes Mellitus / Q000517:prevention & control / Q000534:rehabilitation* / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control / Q000534:rehabilitation / Q000628:therapy; D004734:Energy Metabolism; D019317:Evidence-Based Medicine; D015444:Exercise; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D024821:Metabolic Syndrome / Q000517:prevention & control / Q000534:rehabilitation* / Q000628:therapy; D010809:Physical Fitness
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin